Brief: Nanoviricides Files Prospectus Supplement Related To Issuance, Sale Of Up To $5.7 Mln Common Stock
07/08/2023 15:30
Aug 7 (Reuters) - NanoViricides Inc NNVC.A :
* NANOVIRICIDES - FILES PROSPECTUS SUPPLEMENT RELATED TO
ISSUANCE,
SALE OF COMMON STOCK, OF UP TO $5.7 MILLION FROM TIME TO TIME
THROUGH OR TO SALES AGENT
Further company coverage: NNVC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NanoViricides,
See all newsExplainer: What do we know about the Bundibugyo strain of the Ebola virus?
Brief: anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles
Brief: Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model
Brief: Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments
Brief: Nanoviricides Obtained Right Of First Refusal For All Antiviral Drug Developments